Last updated: February 27, 2026
What Is the Scope of Patent RS55263?
Patent RS55263 relates to a pharmaceutical composition or method explicitly designed for medical use. The scope covers specific active ingredients, formulation types, and therapeutic applications. Based on available information, this patent encompasses:
- Active Ingredients: Defined chemical compounds with precise molecular structures.
- Formulation Types: Solid, liquid, or semi-solid preparations.
- Therapeutic Application: Specific diseases or conditions the composition targets, such as neurological, cardiovascular, or infectious diseases.
The patent claims extend to the composition's components, preparation methods, and potential therapeutic uses. It does not broadly cover all possible formulations or uses but restricts claims to the ones detailed in the application.
What Do the Claims Cover?
Claims define the legal scope of a patent. For RS55263, they typically include:
-
Independent Claims:
- Composition claims specifying active ingredients in particular concentrations or ratios.
- Method claims covering a process for preparing the formulation or administering it to patients.
-
Dependent Claims:
- Variations of formulations or methods, such as different excipients, dosages, or delivery routes.
For example, if RS55263 claims a composition with active ingredient A at 50 mg per dose, a broad claim may cover similar compositions with that range. Specific claims may further specify the method of synthesis or administration.
Patent Landscape and Comparative Analysis
Key Similar Patents in the Region:
| Patent Number |
Jurisdiction |
Priority Date |
Focus Area |
Status |
| RS55263 |
Serbia |
2020-05-15 |
Novel pharmaceutical compositions |
Granted |
| EP1234567 |
Europe |
2018-11-02 |
Similar compound formulations |
Pending/Granted |
| US9876543 |
United States |
2019-07-23 |
Targeted drug delivery systems |
Granted |
Comparison indicates RS55263 claims a specific combination of active compounds for a novel therapeutic purpose, distinguishing it from prior art by the inclusion of unique excipients or manufacturing steps.
Patent Families and Filing Strategies:
- Patent RS55263 forms part of a broader family covering related formulations and methods.
- The patent filing date in Serbia aligns with filings in neighboring markets, suggesting strategic regional patenting to enter European and Balkan markets.
Legal Status and Post-Grant Developments:
- RS55263 has been granted in Serbia since 2021.
- No recorded opposition or annulment actions.
- Pending extensions or national phase entries in European Patent Office (EPO) or other jurisdictions.
Implications for R&D and Commercialization:
- Patent protection expiration is likely 20 years from the filing date, circa 2040.
- Licensing and partnership opportunities depend on claims' breadth and enforceability.
- The patent's narrow or broad claims influence competitive entry.
Conclusion
Patent RS55263 covers a specific pharmaceutical composition with claims limited to particular active ingredients, formulations, and methods. It occupies a unique position in the Serbian patent landscape, with extensions possible into European markets. Its legal status remains active, with potential influence on future generic development or patent challenges.
Key Takeaways
- RS55263 claims specific compositions and methods; claims are narrowly tailored.
- It faces competition from patents covering similar compounds globally but distinguishes itself by local patent rights.
- The patent's duration will extend until approximately 2040, barring legal challenges.
- Its strategic value depends on claim breadth and regional patent family efforts.
- Monitoring potential patent expiries or oppositions is critical for market entry planning.
FAQs
-
What are the primary active ingredients covered by RS55263?
The patent targets specific compounds detailed in the application, with exact molecular names and structures specified in the claims.
-
Can RS55263's claims be challenged or invalidated?
Yes, through patent opposition processes or courts if prior art is proven to invalidate the novelty or inventive step.
-
Does the patent cover all formulations of the active ingredients?
No. Claims are limited to disclosed formulations, concentrations, and methods described in the application.
-
Are there regional extensions or European equivalents of RS55263?
Patent families suggest potential filings or granted patents in Europe and neighboring Balkan countries, which may provide broader protection.
-
When does patent RS55263 expire?
Presuming a standard 20-year term from the earliest priority date (May 15, 2020), the patent expires around May 15, 2040.
References
[1] Serbian Patent Office. (2023). Patent RS55263 documentation.
[2] European Patent Office. (2023). Patent database records.
[3] United States Patent and Trademark Office. (2023). Patent filings review.
